NRXS
NeuraxisยทAMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NRXS Profile
Neuraxis, Inc.
A company that makes devices for children with IBS-related functional abdominal pain
Healthcare Equipment and Supplies
04/17/2012
08/09/2023
American Stock Exchange
21
12-31
Common stock
11611 N. Meridian Street, Suite 330, Carmel, IN 46032
--
Neuraxis, Inc., was founded in 2011 and was incorporated in Indiana on April 17, 2012 as Innovative Health Solutions, Inc. The company is a medical technology company focused on developing neuromodulation therapies to address chronic and debilitating diseases in children and adults. The company is committed to advancing science with proprietary transcutaneous neural electric field stimulation (PENFS) technology developed in-house. The company believes that scientific and evidence-based research excellence is necessary for adoption by the medical and scientific community. Additional clinical trials of PENFS in multiple pediatric conditions are underway with the launch of an FDA indication (functional abdominal pain associated with IBS in adolescents aged 11-18 years).
